0001209191-23-034792.txt : 20230606
0001209191-23-034792.hdr.sgml : 20230606
20230606170701
ACCESSION NUMBER: 0001209191-23-034792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230602
FILED AS OF DATE: 20230606
DATE AS OF CHANGE: 20230606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lloyd George W.
CENTRAL INDEX KEY: 0001814899
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 23996871
MAIL ADDRESS:
STREET 1: C/O ROYALTY PHARMA PLC
STREET 2: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-02
0
0001802768
Royalty Pharma plc
RPRX
0001814899
Lloyd George W.
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET
NEW YORK
NY
10022
0
1
0
0
EVP, Investments & CLO
0
Class A Ordinary Shares
2023-06-02
4
S
0
92221
33.6453
D
120000
I
By GWL 2014 G, LLC
Class A Ordinary Shares
2023-06-02
4
S
0
1686
33.5362
D
128314
I
By GWL 2020 G, LLC
Class A Ordinary Shares
2023-06-05
4
S
0
19215
33.5387
D
109099
I
By GWL 2020 G, LLC
Class A Ordinary Shares
2023-06-06
4
S
0
79099
33.8158
D
30000
I
By GWL 2020 G, LLC
Class A Ordinary Shares
495860
I
By GWL 2013 NG, LLC
Class A Ordinary Shares
273960
I
By IRA
Class A Ordinary Shares
3000
D
Class A Ordinary Shares
4011
I
By Spouse
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.51 to $33.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.53 to $33.55 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $33.69 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.02 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
2023-06-06